PHOENIX—From the value of nonsteroidal anti-inflammatory drugs (NSAIDs) for opioid-sparing pain relief, to the need to follow evidence, not emotion, in clinical decision-making for patients taking glucagon-like peptide-1 (GLP-1) receptor agonist drugs undergoing weight-loss surgery, Girish P. Joshi, MD, MBBS, presented an overview of the topics he considered to be most important published in the past year, at the 2025 annual meeting of the Society for Ambulatory Anesthesia.
“This